New ICD-10 Code Supports AI Sepsis Diagnostic Tools
The Centers for Medicare & Medicaid Services (CMS) has introduced a new ICD-10-PCS code to support AI sepsis diagnostic technologies, including Prenosis' Sepsis ImmunoScore, announced in a press release. Effective October 1, 2025, hospitals can utilize the code XXEZXCB to document the clinical use of these technologies.
This new coding structure marks a significant advancement in the standardization and recognition of computer-aided sepsis diagnostic tools within the healthcare system. It facilitates accurate documentation and tracking of Sepsis ImmunoScore's implementation, which is crucial for clinical quality measurement and reimbursement optimization.
The establishment of this specific code also serves as a prerequisite for New Technology Add-on Payment (NTAP) submission processes, enabling healthcare organizations to integrate Sepsis ImmunoScore into their documentation workflows seamlessly. This development highlights the healthcare industry's commitment to adopting evidence-based diagnostic innovations that enhance sepsis detection and patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AILife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ACL Digital Launches AgentixCare for Healthcare Operations
XpertDox brings autonomous AI medical coding to Camarena Health's Central Valley clinics
Lunit and Summit Test AI Pathology for Ivonescimab Research
AI echo analysis lifts detection of a hard-to-diagnose heart failure type to 78%
DIAGENS releases CT model covering 509 chest and abdominal findings
Daily AI Brief: the AI news that matters, in your inbox.